One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
Sulfadiazine has been studied across 11 research domains including ✨ Skin & Hair, 🧠 Focus & Attention, 🫘 Kidney, 🫁 Liver & Detox, 🦴 Bone & Joint. The primary research focus is ✨ Skin & Hair with 11% of studies addressing this area.
The following compounds share molecular targets with Sulfadiazine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Sulfadiazine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.